Novo Nordisk Adr (NVO)

12:26 PM

HIMS Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Hims & Hers Health, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit - GlobeNewswire Inc.

12:26 PM

Jul 16, 2025

HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - GlobeNewswire Inc.

Jul 16, 2025

Jul 16, 2025

Novo Nordisk’s GLP-1 Reign Faces New Pressures In 2025 - Finimize

Jul 16, 2025

Jul 15, 2025

HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - GlobeNewswire Inc.

Jul 15, 2025

Jul 15, 2025

NVO’s 2025 Market Dance: Down -51.70% – Time to Invest? - investchronicle.com

Jul 15, 2025

Jun 24, 2025

Novo Nordisk's Cardiometabolic Foundation Supports Wide Moat - Morningstar

Jun 24, 2025

Jun 22, 2025

Novo Nordisk: Navigating Challenges to Dominate Diabetes and Obesity Therapies - AInvest

Jun 22, 2025

Jun 19, 2025

The Skinny On Novo Nordisk: This Slimmed-Down Stock May Be Worth A... Shot - Finimize

Jun 19, 2025

Jun 17, 2025

NVO’s Stock Woes: Down -31.04% in 6 Months, Down -31.04% in Just 5 Days - investchronicle.com

Jun 17, 2025

Jun 16, 2025

European Stocks Shine As ADRs Climb Higher - Finimize

Jun 16, 2025

Jun 13, 2025

After ousting CEO, Novo Nordisk reclaims crown as largest European company - MSN

Jun 13, 2025

Jun 10, 2025

Why Novo Nordisk Stock Just Popped - Barchart.com

Jun 10, 2025

May 31, 2025

European ADRs Show Strength With Genfit And Novo Nordisk Leading Gains - Finimize

May 31, 2025

May 30, 2025

European ADRs Show Resilience In US Market - Finimize

May 30, 2025

May 19, 2025

Novo Nordisk Faces Obesity Competition, but Innovation Still Warrants a Wide Moat - Morningstar

May 19, 2025

May 19, 2025

Bio/Pharmaceutical Outsourcing Report, March 2025 Edition - GlobeNewswire Inc.

May 19, 2025

May 16, 2025

European ADRs Dip As Pharma And Tech Stocks See Mixed Results - Finimize

May 16, 2025

May 13, 2025

What Did We Find About Insider Trading At Novo Nordisk ADR (NYSE: NVO)? - Stocksregister

May 13, 2025

May 10, 2025

European Stocks Show Mixed Results With Novo Nordisk Leading Gains - Finimize

May 10, 2025

May 09, 2025

Novo Nordisk Q1 Earnings Match Estimates, Revenues Rise Y/Y, Stock Up - MSN

May 09, 2025

May 08, 2025

Novo Nordisk ADR earnings beat by $5.64, revenue topped estimates - Investing.com Nigeria

May 08, 2025

May 07, 2025

Novo Nordisk Earnings: Compounders Pressured Q1 Wegovy Sales - Morningstar

May 07, 2025

May 07, 2025

Novo Nordisk Earnings: Compounders Pressured Q1 Wegovy Sales, but Strategy Should Preserve Growth - Morningstar

May 07, 2025

May 07, 2025

European ADRs See Mixed Results With Modest Gains - Finimize

May 07, 2025

May 07, 2025

Novo Nordisk expects U.S. sales of Wegovy weight-loss drug to recover soon, CEO says - The Globe and Mail

May 07, 2025

May 07, 2025

Market news - investments.halifax.co.uk

May 07, 2025

May 07, 2025

Novo Nordisk cuts guidance but says generic competition will ease - Sharecast.com

May 07, 2025

May 06, 2025

NOVO_B Stock Price and Chart — OMXCOP:NOVO_B - TradingView

May 06, 2025